Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study

Stege, H. M.; Haist, M.; Schultheis, S.; Fleischer, M. I.; Mohr, P.; Ugurel, S.; Terheyden, P.; Thiem, A.; Kiecker, F.; Leiter, U.; Becker, J. C.; Meissner, M.; Kleeman, J.; Pfoehler, C.; Hassel, J.; Grabbe, S.; Loquai, C.

dc.contributor.author	Leiter-Stöppke, Ulrike
dc.date.accessioned	2022-08-15T07:53:55Z
dc.date.available	2022-08-15T07:53:55Z
dc.date.issued	2021
dc.identifier.issn	0340-7004
dc.identifier.uri	http://hdl.handle.net/10900/130839
dc.language.iso	en	de_DE
dc.publisher	New York	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00262-021-02925-4	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_02194
utue.publikation.seiten	3313-3322	de_DE
utue.personen.roh	Stege, H. M.
utue.personen.roh	Haist, M.
utue.personen.roh	Schultheis, S.
utue.personen.roh	Fleischer, M. I.
utue.personen.roh	Mohr, P.
utue.personen.roh	Ugurel, S.
utue.personen.roh	Terheyden, P.
utue.personen.roh	Thiem, A.
utue.personen.roh	Kiecker, F.
utue.personen.roh	Leiter, U.
utue.personen.roh	Becker, J. C.
utue.personen.roh	Meissner, M.
utue.personen.roh	Kleeman, J.
utue.personen.roh	Pfoehler, C.
utue.personen.roh	Hassel, J.
utue.personen.roh	Grabbe, S.
utue.personen.roh	Loquai, C.
dcterms.isPartOf.ZSTitelID	Cancer Immunology Immunotherapy	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	70	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE